Neil Sengupta to Gastrointestinal Agents
This is a "connection" page, showing publications Neil Sengupta has written about Gastrointestinal Agents.
Connection Strength
0.669
-
Higher vedolizumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease. Scand J Gastroenterol. 2020 Jul; 55(7):800-805.
Score: 0.625
-
Association of Antisecretory Drugs with Upper Gastrointestinal Bleeding in Patients Using Oral Anticoagulants: A Systematic Review and Meta-Analysis. Am J Med. 2022 10; 135(10):1231-1243.e8.
Score: 0.045